Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling

Vascular calcification (VC) is the process of deposition of calcium phosphate crystals in the blood vessel wall, with a central role for vascular smooth muscle cells (VSMCs). VC is highly prevalent in chronic kidney disease (CKD) patients and thought, in part, to be induced by phosphate imbalance. The molecular mechanisms that regulate VC are not fully known. Here we propose a novel role for the mineralisation regulator Ucma/GRP (Upper zone of growth plate and Cartilage Matrix Associated protein/Gla Rich Protein) in phosphate-induced VSMC calcification. We show that Ucma/GRP is present in calcified atherosclerotic plaques and highly expressed in calcifying VSMCs in vitro. VSMCs from Ucma/GRP(-/-) mice showed increased mineralisation and expression of osteo/chondrogenic markers (BMP-2, Runx2, beta-catenin, p-SMAD1/5/8, ALP, OCN), and decreased expression of mineralisation inhibitor MGP, suggesting that Ucma/GRP is an inhibitor of mineralisation. Using BMP signalling inhibitor noggin and SMAD1/5/8 signalling inhibitor dorsomorphin we showed that Ucma/GRP is involved in inhibiting the BMP-2-SMAD1/5/8 osteo/chondrogenic signalling pathway in VSMCs treated with elevated phosphate concentrations. Additionally, we showed for the first time evidence of a direct interaction between Ucma/GRP and BMP-2. These results demonstrate an important role of Ucma/GRP in regulating osteo/chondrogenic differentiation and phosphate-induced mineralisation of VSMCs.NWO ZonMw [MKMD 40-42600-98-13007]; FCT [SFRH/BPD/70277/2010]info:eu-repo/semantics/publishedVersio

The SECURE project – Stem canker of oilseed rape: : molecular methods and mathematical modelling to deploy durable resistance

N Evans et al, "The SECURE Project - Stem Canker of oilseed rape: Molecular methods and mathematical modeling to deploy durable resistance", in Vol 4 of the Proceedings of the 12th International Rapeseed Congress : Sustainable Development in Cruciferous Oilseed Crops Production, Wuhan, China, March 26 - 30, 2007. The proceedings are available online at: http://gcirc.org/intranet/irc-proceedings/12th-irc-wuhan-china-2007-vol-4.htmlModelling done during the SECURE project has demonstrated the dynamic nature of the interaction between phoma stem canker (Leptosphaeria maculans), the oilseed rape host (Brassica napus) and the environment. Experiments done with near-isogenic lines of L. maculans to investigate pathogen fitness support field data that suggest a positive effect of the avirulence allele AvrLm4 on pathogen fitness, and that the loss of this allele renders isolates less competitive under field conditions on cultivars without the resistance gene Rlm4. The highlight of molecular work was the cloning of AvrLm1 and AvrLm6. L. maculans is now one of the few fungal species for which two avirulence loci have been cloned. Subsequent research focused on understanding the function of AvrLm1 and AvrLm6 and on the analysis of sequences of virulent isolates to understand molecular evolution towards virulence. Isolates of L. maculans transformed with GFP and/or DsRed were used to follow growth of the fungus in B. napus near-isogenic-lines (NIL) with or without MX (Rlm6) resistance under different temperature and wetness conditions. The results greatly enhanced our knowledge of the infection process and the rate and extent of in planta growth on different cultivars. Conclusions from work to model durability of resistance have been tested under field conditions through a series of experiments to compare durability of resistance conferred by the major resistance gene Rlm6 alone in a susceptible background (EurolMX) or in a resistant background (DarmorMX) under recurrent selection over 4 growing seasons. A major priority of the project was knowledge transfer of results and recommendations to target audiences such as plant breeding companies and extension services. CETIOM developed a “diversification scheme” that encourages French growers to make an informed choice about the cultivars that are grown within the rotation based on the resistance genes carried by the individual cultivars. Use of such schemes, in association with survey data on the population structure of L. maculans at both national and European scales will provide opportunities for breeders and the industry to manage available B. napus resistance more effectively.Non peer reviewe

Teatro na educação de crianças e adolescentes participantes de ensaio clínico

OBJETIVO: Analisar os efeitos de uma intervenção pedagógica na aprendizagem de crianças e adolescentes participantes de pesquisa clínica. MÉTODOS: Estudo quantitativo, quasi-experimental e longitudinal, parte de um conjunto de estudos envolvidos no teste de uma vacina contra ancilostomíase. Amostra por conveniência com 133 estudantes de dez a 17 anos, de ambos os sexos, da Escola Municipal de Maranhão, MG, Brasil, 2009. Utilizou-se um questionário estruturado aplicado pré e pós-intervenção. O dispositivo pedagógico foi o Teatro do Oprimido. As variáveis dependentes foram o conhecimento específico e global sobre pesquisa clínica e sobre verminoses; a variável independente foi a participação na intervenção educativa. RESULTADOS: Houve aumento do conhecimento sobre sinais e sintomas, susceptibilidade à reinfecção e modo de contágio da verminose após a intervenção educativa. Aumentaram acertos relativos à duração da pesquisa clínica, aos procedimentos previstos, à possibilidade de desistência da participação e de ocorrência de eventos adversos. Permaneceu a noção de que o propósito primário da pesquisa é terapêutico, embora tenha reduzido o percentual de participantes que associaram a pesquisa ao tratamento médico. O Teatro do Oprimido possibilitou que as discussões acerca da helmintose e da pesquisa clínica fossem contextualizadas e materializadas. Os sujeitos puderam se despojar ou reduzir suas representações prévias. CONCLUSÕES: A participação de crianças e adolescentes em ensaios clínicos deve ser precedida de intervenção educativa, já que indivíduos dessa faixa etária nem sequer reconhecem que têm direito a decidir por si próprios

Ethics takes time, but not that long

© 2007 Hansson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

How do parents experience being asked to enter a child in a randomised controlled trial?

<p>Abstract</p> <p>Background</p> <p>As the number of randomised controlled trials of medicines for children increases, it becomes progressively more important to understand the experiences of parents who are asked to enrol their child in a trial. This paper presents a narrative review of research evidence on parents' experiences of trial recruitment focussing on qualitative research, which allows them to articulate their views in their own words.</p> <p>Discussion</p> <p>Parents want to do their best for their children, and socially and legally their role is to care for and protect them yet the complexities of the medical and research context can challenge their fulfilment of this role. Parents are simultaneously responsible for their child and cherish this role yet they are dependent on others when their child becomes sick. They are keen to exercise responsibility for deciding to enter a child in a trial yet can be fearful of making the 'wrong' decision. They make judgements about the threat of the child's condition as well as the risks of the trial yet their interpretations often differ from those of medical and research experts. Individual pants will experience these and other complexities to a greater or lesser degree depending on their personal experiences and values, the medical situation of their child and the nature of the trial. Interactions at the time of trial recruitment offer scope for negotiating these complexities if practitioners have the flexibility to tailor discussions to the needs and situation of individual parents. In this way, parents may be helped to retain a sense that they have acted as good parents to their child whatever decision they make.</p> <p>Summary</p> <p>Discussing randomised controlled trials and gaining and providing informed consent is challenging. The unique position of parents in giving proxy consent for their child adds to this challenge. Recognition of the complexities parents face in making decisions about trials suggests lines for future research on the conduct of trials, and ultimately, may help improve the experience of trial recruitment for all parties.</p